ScholarWorks@한양대학교

상세 보기

Efficacy and Safety of a Novel Subcutaneous Formulation of CT- P13 over the 1- year Treatment Period and After Switching from Intravenous CT- P13 in Patients with Active Rheumatoid Arthritis: Results from Part 2 of Phase I/III Randomized Controlled Trial

  • 유대현
제목
Efficacy and Safety of a Novel Subcutaneous Formulation of CT- P13 over the 1- year Treatment Period and After Switching from Intravenous CT- P13 in Patients with Active Rheumatoid Arthritis: Results from Part 2 of Phase I/III Randomized Controlled Trial
저자
유대현
발행일
2019-11-10
학회명
ACR 2019
개최지
Atlanta, USA

ScholarWorks@한양대학교

(04763) 서울특별시 성동구 왕십리로 222 Tel. +82-2-2220-1370 +82-2-2220-1366

COPYRIGHT © 한양대학교 All Rights Reserved.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.

You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.